These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


425 related items for PubMed ID: 4036939

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
    Nomura F, Ohnishi K, Ohto M, Takeda Y, Rikihisa T, Kanakubo Y.
    Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
    [Abstract] [Full Text] [Related]

  • 5. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
    Hashimoto M, Watanabe G.
    J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis.
    Merkel C, Gatta A, Caregaro L, Sacerdoti D, Rondana M, Ruol A.
    Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT, Marigold JH, Thompson RP.
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatic metabolic function in patients receiving long-term methotrexate therapy: comparison with topically treated psoriatics, patient controls and cirrhotics.
    Birnie GG, Fitzsimons CP, Czarnecki D, Cooke A, Scobie G, Brodie MJ.
    Hepatogastroenterology; 1985 Aug; 32(4):163-7. PubMed ID: 2865199
    [Abstract] [Full Text] [Related]

  • 17. [Effect of pneumoperitoneum on the liver blood flow in cirrhotic rats].
    Xu D, Sun J, Li F, Li D, Liu J, Sun H, Liu S.
    Zhonghua Wai Ke Za Zhi; 2002 Sep; 40(9):696-8. PubMed ID: 12411144
    [Abstract] [Full Text] [Related]

  • 18. Hepatic function and portal hemodynamics in patients with liver cirrhosis.
    Kawasaki T, Moriyasu F, Kimura T, Someda H, Tamada T, Yamashita Y, Ono S, Kajimura K, Hamato N, Okuma M.
    Am J Gastroenterol; 1990 Sep; 85(9):1160-4. PubMed ID: 2202201
    [Abstract] [Full Text] [Related]

  • 19. Comparison of indocyanine green clearance with Child's-Pugh score and hepatic histology: a multivariate analysis.
    Mukherjee S, Rogers MA, Buniak B.
    Hepatogastroenterology; 2006 Sep; 53(67):120-3. PubMed ID: 16506389
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.